Health Care: Drugs

Eli Lilly and Company (LLY: NYSE)

$54.74 -0.18 | -0.33%
05/23/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 22.60B 24.29B 23.08B 21.84B
Cost of Sales 3.33B 3.69B 3.04B 2.95B
Gross Operating Profit 19.27B 20.59B 20.04B 18.89B
Selling, General, and Administrative Expenses 7.51B 7.88B 7.05B 6.89B
Research & Development 5.28B 5.02B 4.88B 4.33B
Operating Income before D & A (EBITDA) 6.48B 7.69B 8.10B 7.67B
Depreciation & Amortization 1.46B 1.37B 1.33B 1.30B
Interest Income 105.00M 79.90M 51.90M 75.20M
Other Income - Net 0.00 -72.90M 128.60M -43.40M
Special Income / Charges 465.70M -1.18B -292.00M -872.70M
Total Income Before Interest Expenses (EBIT) 5.59B 5.54B 6.71B 5.62B
Interest Expense 177.80M 186.00M 185.50M 261.30M
Pre-Tax Income 5.41B 5.35B 6.53B 5.36B
Income Taxes 1.32B 1.00B 1.46B 1.03B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 4.09B 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 4.09B 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 4.09B 4.35B 5.07B 4.33B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.62B 789.40M 242.00M 782.70M
Preferred Dividends
Net Income Available To Common 4.09B 0.00 0.00 0.00
Basic EPS from Continuing Ops. 3.67 3.90 4.58 3.94
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.67 3.90 4.58 3.94
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.67 3.90 4.58 3.94
Basic Normalized Net Income/Share 3.25 n.a. n.a. n.a.
EPS fr Continuing Ops. 3.66 3.90 4.58 3.94
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.66 3.90 4.58 3.94
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.66 3.90 4.58 3.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.24 n.a. n.a. n.a.
Dividends Paid per Share 1.96 1.96 1.96 1.96

Portfolios with LLY

View All

Latest LLY Headlines from TheStreet

More Financial News for LLY

Press Releases for LLY

See All Press Releases

Partner Headlines for LLY

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter